SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

MARZOLA, Erika
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.145
AS - Asia 2.706
EU - Europa 1.735
SA - Sud America 389
AF - Africa 71
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 2
Totale 10.057
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.032
SG - Singapore 1.044
CN - Cina 606
IT - Italia 489
VN - Vietnam 306
BR - Brasile 272
DE - Germania 260
HK - Hong Kong 211
GB - Regno Unito 174
PL - Polonia 165
UA - Ucraina 161
BD - Bangladesh 119
FI - Finlandia 116
TR - Turchia 112
FR - Francia 102
JP - Giappone 67
CA - Canada 66
SE - Svezia 62
IN - India 57
RU - Federazione Russa 56
ID - Indonesia 47
AR - Argentina 40
MX - Messico 35
NL - Olanda 34
ZA - Sudafrica 31
BE - Belgio 27
CO - Colombia 26
PK - Pakistan 21
IQ - Iraq 20
LT - Lituania 17
EC - Ecuador 14
ES - Italia 14
IR - Iran 12
SA - Arabia Saudita 12
AT - Austria 11
IE - Irlanda 11
PH - Filippine 11
MY - Malesia 9
UY - Uruguay 9
TN - Tunisia 8
UZ - Uzbekistan 8
CL - Cile 7
DZ - Algeria 7
PY - Paraguay 7
VE - Venezuela 7
AE - Emirati Arabi Uniti 6
AU - Australia 6
CZ - Repubblica Ceca 6
IL - Israele 6
JO - Giordania 6
MA - Marocco 6
AL - Albania 5
BG - Bulgaria 5
KE - Kenya 4
KZ - Kazakistan 4
PE - Perù 4
RO - Romania 4
BO - Bolivia 3
GR - Grecia 3
HU - Ungheria 3
KR - Corea 3
LB - Libano 3
NI - Nicaragua 3
TH - Thailandia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AO - Angola 2
AZ - Azerbaigian 2
CH - Svizzera 2
ET - Etiopia 2
NA - Namibia 2
NZ - Nuova Zelanda 2
PA - Panama 2
PT - Portogallo 2
SN - Senegal 2
TW - Taiwan 2
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
BW - Botswana 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CV - Capo Verde 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EE - Estonia 1
EG - Egitto 1
GA - Gabon 1
GE - Georgia 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
KW - Kuwait 1
LK - Sri Lanka 1
LV - Lettonia 1
MU - Mauritius 1
NG - Nigeria 1
NP - Nepal 1
NR - Nauru 1
OM - Oman 1
QA - Qatar 1
Totale 10.052
Salva come PNG Salva come JPEG
Città #
Ashburn 683
Singapore 677
Fairfield 423
Woodbridge 405
San Jose 375
Ann Arbor 238
Beijing 224
Houston 223
Santa Clara 211
Hong Kong 203
Seattle 186
Jacksonville 169
Chandler 166
Ferrara 166
Warsaw 159
Cambridge 149
Wilmington 147
New York 144
Ho Chi Minh City 101
Los Angeles 95
Munich 89
Dallas 80
Milan 70
Tokyo 66
Hanoi 62
Izmir 60
Princeton 52
Lauterbourg 50
Council Bluffs 49
Helsinki 48
Dearborn 47
Nanjing 47
Addison 44
Shanghai 40
San Diego 38
Jakarta 33
Boardman 31
Turku 31
São Paulo 30
London 27
Bologna 26
The Dalles 26
Atlanta 25
Brussels 25
Frankfurt am Main 25
Orem 23
Buffalo 21
Mexico City 21
Montreal 21
Chicago 20
Johannesburg 20
Brooklyn 19
Falkenstein 19
Toronto 18
Auburn Hills 16
Hefei 16
Redwood City 16
Denver 15
Manchester 15
Nanchang 15
Haiphong 14
Phoenix 14
Boston 12
Bremen 12
San Mateo 12
Tianjin 12
Turin 12
Ferrara di Monte Baldo 11
Medellín 11
San Francisco 11
Shenyang 11
Stockholm 11
Washington 11
Biên Hòa 10
Changsha 10
Charlotte 10
Da Nang 10
Dublin 10
Hebei 10
Lahore 10
Moscow 10
Mountain View 10
Rome 10
Chennai 9
Istanbul 9
Montevideo 9
Padova 9
Philadelphia 9
Poplar 9
Florence 8
Jinan 8
New Delhi 8
Norwalk 8
Amsterdam 7
Augusta 7
Baghdad 7
Bexley 7
Columbus 7
Jeddah 7
Jiaxing 7
Totale 6.929
Salva come PNG Salva come JPEG
Nome #
A novel and facile synthesis of tetra branched derivatives of nociceptin/orphanin FQ 290
Involvement of cell surface TG2 in the aggregation of K562 cells triggered by gluten 289
Design and synthesis of99mTcN-labeled dextran-mannose derivatives for sentinel lymph node detection 289
[Dmt(1) ]N/OFQ(1-13)-NH(2) , a potent nociceptin/orphanin FQ and opioid receptor universal agonist. 269
[(t)Bu-d-Gly(5)]NPS, a pure and potent antagonist of the neuropeptide S receptor: In vitro and in vivo studies 251
Naphthoquinone amino acid derivatives, synthesis and biological activity as proteasome inhibitors 245
N- and C-terminal modifications of nociceptin/orphanin FQ generate highly potent NOP receptor ligands 243
Biased Agonism at Nociceptin/Orphanin FQ Receptors: A Structure Activity Study on N/OFQ(1-13)-NH2 243
Structure-and conformation-Activity studies of nociceptin/orphanin FQ receptor dimeric ligands 242
Structure activity studies of nociceptin/orphanin FQ(1–13)-NH2 derivatives modified in position 5 240
Cell and tissue responses of a range of Urotensin II analogs at cloned and native urotensin II receptors. Evidence for coupling promiscuity 239
Tryptophan replacement in the nociceptin/orphanin FQ receptor ligand Ac-RYYRWK-NH2 230
Conformation-activity relationship of neuropeptide S and some structural mutants: Helicity affects their interaction with the receptor 224
Physicochemical stability of cabazitaxel and docetaxel solutions 219
Pharmacological characterization of tachykinin tetrabranched derivatives 215
Synthesis and biological activity of human neuropeptide S analogues modified in position 2 212
In vitro and in vivo pharmacological characterization of nociceptin/orphanin FQ tetrabranched derivatives 212
Further studies at neuropeptide S position 5: Discovery of novel neuropeptide S receptor antagonists 208
Synthesis and biological activity of nociceptin/orphanin FQ analogues substituted in position 7 or 11 with C alpha,alpha-dialkylated amino acids 201
Synthesis and Biological Activity of Human Neuropeptide S Analogues Modified in Position 5: Identification of Potent and Pure Neuropeptide S Receptor Antagonists 199
In vitro and in vivo pharmacological characterization of the neuropeptide S receptor antagonist [D-Cys(tBu)5]neuropeptide S 198
Structure-activity study at positions 3 and 4 of human neuropeptide S. 195
Pharmacological profile of the neuropeptide S receptor: Dynamic mass redistribution studies 193
Tetrabranched Hetero-Conjugated Peptides as Bifunctional Agonists of the NOP and Mu Opioid Receptors 193
Pharmacology of Kappa Opioid Receptors: Novel Assays and Ligands 191
ANALOGHI DERMASEPTINICI AD ATTIVITA’ ANTIMICROBICA 190
How terminal protection affects the chemical and biological properties of the antimicrobial calcitermin 189
Disordered Peptides Looking for Their Native Environment: Structural Basis of CB1 Endocannabinoid Receptor Binding to Pepcans 185
Impaired Priming of SARS-CoV-2-Specific Naive CD8+ T Cells in Older Subjects 185
Structure-activity relationship study of position 4 in the urotensin-II receptor ligand U-II(4-11) 179
Structure-activity relationship study on human urotensin II 176
Synthesis of 2,6-Dimethyltyrosine-Like Amino Acids through Pinacolinamide-Enabled C-H Dimethylation of 4-Dibenzylamino Phenylalanine 175
In vitro and in vivo pharmacological characterization of the novel UT receptor ligand [Pen(5), DTrp(7), Dab(8)] urotensin II(4-11) (UFP-803) 172
Urantide mimics urotensin-II induced calcium release in cells expressing recombinant UT receptors 168
Structure-activity studies on neuropeptide S - Identification of the amino acid residues crucial for receptor activation 167
Structure-activity relationship study on Tyr9 of urotensin-II(4-11): Identification of a partial agonist of the UT receptor 167
Novel Mixed NOP/Opioid Receptor Peptide Agonists 164
Thermodynamic and spectroscopic investigation on the role of Met residues in CuII binding to the non-octarepeat site of the human prion protein 162
Synthesis and antimicrobial activity of dermaseptin S1 analogues 161
Structure-Activity Relationship Studies on Oxazolo[3,4- a]pyrazine Derivatives Leading to the Discovery of a Novel Neuropeptide S Receptor Antagonist with Potent in Vivo Activity 161
Role of 2′,6′-dimethyl-l-tyrosine (Dmt) in some opioid lead compounds 145
Impact of C- and N-terminal protection on the stability, metal chelation and antimicrobial properties of calcitermin 142
CCR4+ CD8+ T cells clonally expand to differentiated effectors in murine psoriasis and in human psoriatic arthritis 141
A Multi-Angle Approach to Predict Peptide-GPCR Complexes: The N/OFQ-NOP System as a Successful AlphaFold Application Case Study 139
Use of a Novel Peptide Welding Technology Platform for the Development of B- and T-Cell Epitope-Based Vaccines 135
The N-terminal domain of Helicobacter pylori's Hpn protein: The role of multiple histidine residues 125
Manganese complexes for multimodal PET/MRI imaging: progress of METRICS project 116
In vitro pharmacological characterization of growth hormone secretagogue receptor ligands using the dynamic mass redistribution and calcium mobilization assays 115
METRICS project: Synthesis of Manganese Complexes as potential PET/MRI Agents 113
Positively charged residues play a significant role in enhancing the antibacterial activity of calcitermin 109
Synthesis and characterization of manganese dithiocarbamate complexes: New evidence of dioxygen activation 109
Racemic synthesis and solid phase peptide synthesis application of the chimeric valine/leucine derivative 2-amino-3,3,4-trimethyl-pentanoic acid 100
null 94
Production and Characterization of Semi-Solid Formulations for the Delivery of the Cosmetic Peptide Palmitoyl-GHK 82
Nonpeptide/peptide chimeric ligands for the nociceptin/orphanin FQ receptor: design, synthesis and in vitro pharmacological activity 78
Synthesis and Pharmacological Characterization of Nociceptin/Orphanin FQ Dimeric Ligands 76
null 42
Totale 10.192
Salva come PNG Salva come JPEG
Categoria #
all - tutte 45.219
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 599
Totale 45.818
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202141 0 0 0 0 0 0 0 0 0 0 0 41
2021/2022595 28 53 47 42 33 14 35 37 37 51 55 163
2022/2023485 58 31 26 54 62 50 55 50 46 2 29 22
2023/2024396 31 41 26 10 16 90 17 46 10 11 18 80
2024/20251.453 35 29 146 62 175 142 28 71 255 129 188 193
2025/20264.317 460 158 329 481 624 322 532 229 352 456 246 128
Totale 10.192